Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Mirum Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +11 vs. Q4 2024
- Shares held
- 54.1M
- +1.88M (+3.6%) vs. Q4 2024
- Total value
- $2.44B
- +$282.7M (+13.1%) vs. Q4 2024
- New holders
- 35
- 85 more added
- Sold out
- 24
- 66 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 326 | $8.36B |
| Q1 2026 | 311 | $6.29B |
| Q4 2025 | 284 | $4.82B |
| Q3 2025 | 272 | $4.20B |
| Q2 2025 | 214 | $2.82B |
| Q1 2025 | 214 | $2.44B |
| Q4 2024 | 205 | $2.19B |
| Q3 2024 | 178 | $2.08B |
| Q2 2024 | 161 | $1.83B |
| Q1 2024 | 172 | $1.34B |
| Q4 2023 | 187 | $1.48B |
| Q3 2023 | 159 | $1.55B |
| Q2 2023 | 146 | $955.6M |
| Q1 2023 | 117 | $832.9M |
| Q4 2022 | 104 | $650.2M |
| Q3 2022 | 112 | $709.1M |
| Q2 2022 | 110 | $569.4M |
| Q1 2022 | 99 | $590.4M |
| Q4 2021 | 86 | $395.7M |
| Q3 2021 | 73 | $465.0M |
| Q2 2021 | 67 | $404.6M |
| Q1 2021 | 61 | $463.3M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Mirum Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 963,665 | $43.4M | 0.00% | +20,321+2.2% | Added |
| Clearbridge Investments, LLC | 978,067 | $44.1M | 0.04% | +70,750+7.8% | Added |
| Polar Capital Holdings Plc | 1,175,000 | $52.9M | 0.33% | +500,000+74.1% | Added |
| Tang Capital Management LLC | 1,237,107 | $55.7M | 3.08% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,415,137 | $63.8M | 0.01% | −7,592−0.5% | Reduced |
| Citadel Advisors LLC | 1,445,995 | $65.1M | 0.06% | −65,188−4.3% | Reduced |
| State Street Corp | 1,494,566 | $67.3M | 0.00% | +112,939+8.2% | Added |
| Novo Holdings A/S | 1,500,000 | $67.6M | 5.14% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 2,527,000 | $113.9M | 2.27% | −79,938−3.1% | Reduced |
| Vanguard Group Inc | 2,540,061 | $114.4M | 0.00% | +115,327+4.8% | Added |
| BVF Inc | 2,796,513 | $126.0M | 5.13% | 00.0% | Unchanged |
| BlackRock, Inc. | 3,339,557 | $150.4M | 0.00% | −95,071−2.8% | Reduced |
| Janus Henderson Group PLC | 4,766,109 | $219.2M | 0.12% | +184,467+4.0% | Added |
| Frazier Life Sciences Management, L.P. | 6,795,121 | $306.1M | 13.99% | +224,729+3.4% | Added |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −589,579−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −190,476−100.0% | Sold out |
| Ardsley Advisory Partners LP | 0 | $0 | 0.00% | −190,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −175,913−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −41,800−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −23,966−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −20,944−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −14,861−100.0% | Sold out |
| Alpha DNA Investment Management LLC | 0 | $0 | 0.00% | −10,663−100.0% | Sold out |
| Congress Wealth Management LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −9,158−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −8,270−100.0% | Sold out |
| Syon Capital LLC | 0 | $0 | 0.00% | −6,682−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −6,587−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −6,355−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −5,707−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −2,499−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −1,680−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −856−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −543−100.0% | Sold out |
| Pathway Financial Advisers, LLC | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Hanseatic Management Services Inc | – | – | – | – | Not filed |